- Home
- INCR vs APYX Comparison
INCR vs APYX Comparison
Compare INCR & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCR
- APYX
- Stock Information
- Founded
- INCR 1994
- APYX 1982
- Country
- INCR Israel
- APYX United States
- Employees
- INCR N/A
- APYX N/A
- Industry
- INCR Biotechnology: Pharmaceutical Preparations
- APYX Medical/Dental Instruments
- Sector
- INCR Health Care
- APYX Health Care
- Exchange
- INCR Nasdaq
- APYX Nasdaq
- Market Cap
- INCR 76.7M
- APYX 61.7M
- IPO Year
- INCR N/A
- APYX 1987
- Fundamental
- Price
- INCR $1.64
- APYX $1.51
- Analyst Decision
- INCR
- APYX Hold
- Analyst Count
- INCR 0
- APYX 2
- Target Price
- INCR N/A
- APYX N/A
- AVG Volume (30 Days)
- INCR 27.5K
- APYX 16.8K
- Earning Date
- INCR 03-04-2025
- APYX 03-20-2025
- Dividend Yield
- INCR N/A
- APYX N/A
- EPS Growth
- INCR N/A
- APYX N/A
- EPS
- INCR N/A
- APYX N/A
- Revenue
- INCR $72,420,918.00
- APYX $48,542,000.00
- Revenue This Year
- INCR N/A
- APYX N/A
- Revenue Next Year
- INCR $39.30
- APYX $2.50
- P/E Ratio
- INCR N/A
- APYX N/A
- Revenue Growth
- INCR N/A
- APYX N/A
- 52 Week Low
- INCR $1.17
- APYX $0.97
- 52 Week High
- INCR $3.72
- APYX $2.30
- Technical
- Relative Strength Index (RSI)
- INCR 48.90
- APYX 53.42
- Support Level
- INCR $1.61
- APYX $1.42
- Resistance Level
- INCR $1.73
- APYX $1.56
- Average True Range (ATR)
- INCR 0.06
- APYX 0.08
- MACD
- INCR -0.01
- APYX 0.01
- Stochastic Oscillator
- INCR 35.48
- APYX 81.41
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.